WCM
BMY icon

Winthrop Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Winthrop Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-152
Closed -$8K – 331
2024
Q3 		$8K Buy
+152
New +$7.13K ﹤0.01% 118

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winthrop Capital Management's BMY Position: Q1 2026 in Review

Winthrop Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 152 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Winthrop Capital Management first reported a position in BMY in Q4 2023 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Winthrop Capital Management held 152 shares of Bristol-Myers Squibb worth $9K as of Q1 2026.
  • Winthrop Capital Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Winthrop Capital Management's portfolio in Q1 2026, its #239 holding.
  • Winthrop Capital Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 6 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.